BIOX Stock Analysis: Buy, Sell, or Hold?
BIOX - Bioceres Crop Solutions Corp. Ordinary Shares
$0.23
-0.02 (-8.00%)
▼
5d:
-14.86%
30d:
-36.78%
90d:
-28.73%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 11, 2026
17d
Get Alerted When BIOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BIOX is down 14.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BIOX is down 14.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIOX is currently trading at $0.23, which is considered oversold relative to its 30-day fair value range of $0.28 to $0.38. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.7) compared to its historical average (10.3). Remarkably, the market is currently pricing in an annual earnings decline of 23.1% over the next few years. This pessimistic expectation contrasts with the company's recent 34.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BIOX is in a downtrend. Immediate support is located at $0.19, while resistance sits at $0.33. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: BIOX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.00 (+752.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOX is in a downtrend. Immediate support is located at $0.19, while resistance sits at $0.33. Short-term momentum is weak, with the stock down 8.0% recently.
Market Sentiment: BIOX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.00 (+752.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.28 -
$0.38
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.0%)
- BULLISH: Trading 752.5% below Wall St target ($2.00)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.38
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$0.33
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.69
Wall Street Target
$2.00
(+752.5%)
Revenue Growth (YoY)
-23.4%
Earnings Growth (YoY)
34.4%
Profit Margin
-19.7%
Valuation Discount vs History
-23.1% cheaper
PE vs Historical
4.7 vs 10.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.1%
(market-implied from PE analysis)
1-Year Target
$0.21
(-10%)
2-Year Target
$0.19
(-19%)
3-Year Target
$0.17
(-27%)
3-Yr Target (if PE normalizes)
(PE: 5→10)
$0.38
(+60%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.7 to 10.3
Stabilization Target:
$0.52
(+119.5%)
PE Expansion Potential:
+119.5%
Share & Embed Analysis
Last updated: October 23, 2026 8:50 PM ET
Data refreshes hourly during market hours. Next update: 9:50 PM
Data refreshes hourly during market hours. Next update: 9:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Agricultural Inputs Stocks
Top-rated stocks in Agricultural Inputs by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTR
Nutrien Ltd |
BUY
25 analysts |
$77 | 61 BUY |
|
MOS
The Mosaic Company |
HOLD
20 analysts |
$26 | 53 HOLD |
|
CTVA
Corteva Inc |
STRONG BUY
12 analysts |
$17 | 57 HOLD |
|
CF
CF Industries Holdings I… |
SELL
22 analysts |
$128 | 43 HOLD |
|
FMC
FMC Corporation |
SELL
17 analysts |
$9 | 50 HOLD |
